Two Sigma Investments, LP Editas Medicine, Inc. Transaction History
Two Sigma Investments, LP
- $42.8 Billion
- Q1 2025
A detailed history of Two Sigma Investments, LP transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 1,249,775 shares of EDIT stock, worth $2.86 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,249,775
Previous 1,649,072
24.21%
Holding current value
$2.86 Million
Previous $2.09 Million
30.8%
% of portfolio
0.0%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding EDIT
# of Institutions
223Shares Held
47.8MCall Options Held
436KPut Options Held
324K-
Black Rock Inc. New York, NY7.78MShares$17.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$16.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.66MShares$6.09 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL2.6MShares$5.95 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$4.5 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $157M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...